An anonymous reader quotes a report from Reuters: U.S. health regulators could approve a third COVID-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced eight-month gap, the Wall Street Journal reported on Wednesday. Approval of boosters for three COVID-19 shots being administered in the United States — those manufactured by Pfizer and partner BioNTech, Moderna and Johnson & Johnson — is expected in mid-September, the report said, citing a person familiar with the plans.

Pfizer and BioNTech have already started the application process for the approval of its booster shot in people 16 and older, saying it spurs a more than three-fold increase in antibodies against the coronavirus. Earlier this week, U.S. regulators granted full approval to Pfizer’s two-dose vaccine. Moderna said on Wednesday it has completed the real-time review needed for a full approval for its jab in people 18 and above. Earlier today, Johnson & Johnson announced that booster doses of its one-shot coronavirus vaccine generated a big spike in antibodies. “People who received a booster six to eight months after their initial J&J shots saw antibodies increase nine-fold higher than 28 days after the first shot,” reports CNN, citing Johnson & Johnson.

Read more of this story at Slashdot.

Source: Slashdot – US Plans COVID-19 Booster Shots At Six Months Instead of Eight